NOVAVAX INC (NVAX) Operating income 2016–2025
NOVAVAX INC (NVAX) annual operating income history from SEC filings — each fiscal year as reported.
$452.8MFY2025 · since FY2016: -$269.1M → $452.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $452.8M | +281.9% |
| FY2024 | -$248.9M | +56.1% |
| FY2023 | -$566.5M | +12.1% |
| FY2022 | -$644.7M | +61.8% |
| FY2021 | -$1.7B | -304.7% |
| FY2020 | -$416.7M | -245.6% |
| FY2019 | -$120.6M | +30.7% |
| FY2018 | -$173.9M | -1.3% |
| FY2017 | -$171.7M | +36.2% |
| FY2016 | -$269.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVAX financial trends
NVAX RevenueNVAX Net incomeNVAX Net marginNVAX Gross profitNVAX Gross marginNVAX Operating marginNVAX Operating cash flowNVAX Free cash flowNVAX Capital expendituresNVAX Return on equityNVAX Stock buybacksNVAX Dividends paidNVAX Total assetsNVAX Total liabilitiesNVAX Shareholders’ equityNVAX overview →